Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin

Toxicological Sciences

Volumn 137, Issue 1, 2014, Pages 114-124

  Pierre, Stéphane ^a,b   Chevallier, Aline ^a,b   Teixeira Clerc, Fatima ^c   Ambolet Camoit, Ariane ^a,b   Bui, Linh Chi ^a,b   Bats, Anne Sophie ^a,b,d   Fournet, Jean Christophe ^e   Fernandez Salguero, Pedro ^f   Aggerbeck, Martine ^a,b   Lotersztajn, Sophie ^c   Barouki, Robert ^a,b,e   Coumoul, Xavier ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

AhR; Dioxin; Inflammation; Liver diseases; Mice

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; CLAUDIN 1; COLLAGEN 1A1; COLLAGEN TYPE 1; INTERLEUKIN 1BETA; MICRORNA 200A; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; AHR PROTEIN, HUMAN; AHR PROTEIN, MOUSE; AROMATIC HYDROCARBON RECEPTOR; AUTACOID; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; LIGAND; POLLUTANT; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; POLLUTANT; PROTEIN EXPRESSION; TREATMENT DURATION; UPREGULATION; AGONISTS; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; TIME; TOXICITY;

GASTROPODA; MURINAE; MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; ENVIRONMENTAL POLLUTANTS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INFLAMMATION MEDIATORS; LIGANDS; LIVER; LIVER CIRRHOSIS; MICE; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84891294432     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft236     Document Type: Article

References (45)

1. Akiri, G., Sabo, E., Dafni, H., Vadasz, Z., Kartvelishvily, Y., Gan, N., Kessler, O., Cohen, T., Resnick, M., Neeman, M., et al. (2003). Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res. 63, 1657-1666.
2. Altamirano, J., and Bataller, R. (2010). Cigarette smoking and chronic liver diseases. Gut 59, 1159-1162. doi: 10.1136/gut.2008.162453.
3. Barouki, R., Coumoul, X., and Fernandez-Salguero, P. M. (2007). The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 581, 3608-3615.
4. Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383-1394. doi: 10.1172/ JCI18212.
5. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., and Zacharewski, T. R. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398-416. doi: 10.1093/toxsci/kfl100.
6. Brenner, D. A., Waterboer, T., Choi, S. K., Lindquist, J. N., Stefanovic, B., Burchardt, E., Yamauchi, M., Gillan, A., and Rippe, R. A. (2000). New aspects of hepatic fibrosis. J. Hepatol. 32(1 Suppl.), 32-38.
7. Bui, L. C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A. S., Mota, S., Raingeaud, J., Pierre, J., Diry, M., Transy, C., et al. (2009). Nedd9/Hef1/ Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene 28, 3642-3651. doi: 10.1038/onc.2009.224.
8. Butler, R., Inzunza, J., Suzuki, H., Fujii-Kuriyama, Y., Warner, M., and Gustafsson, J. Å. (2012). Uric acid stones in the urinary bladder of aryl hydrocarbon receptor (AhR) knockout mice. Proc. Natl. Acad. Sci. U.S.A. 109, 1122-1126. doi: 10.1073/pnas.1120581109.
9. Carvajal-Gonzalez, J. M., Mulero-Navarro, S., Roman, A. C., Sauzeau, V., Merino, J. M., Bustelo, X. R., and Fernandez-Salguero, P. M. (2009). The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Mol. Biol. Cell 20, 1715-1727. doi: 10.1091/mbc.E08-05-0451.
10. Chang, X., Fan, Y., Karyala, S., Schwemberger, S., Tomlinson, C. R., Sartor, M. A., and Puga, A. (2007). Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol. Cell. Biol. 27, 6127-6139. doi: 10.1128/ MCB.00323-07.
11. Chen, P., and Parks, W. C. (2009). Role of matrix metalloproteinases in epithelial migration. J. Cell. Biochem. 108, 1233-1243. doi: 10.1002/jcb.22363.
12. Choi, S. S., and Diehl, A. M. (2009). Epithelial-to-mesenchymal transitions in the liver. Hepatology 50, 2007-2013. doi: 10.1002/hep.23196.
13. Connor, K. T., and Aylward, L. L. (2006). Human response to dioxin: Aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ Health. B Crit. Rev. 9, 147-171. doi: 10.1080/15287390500196487. pii: K22N5M027837359U.
14. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867. doi: 10.1038/nature01322.
15. Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., and Zhao, B. (2011). Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124, 1-22. doi: 10.1093/toxsci/kfr218.
16. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K. W., Barouki, R., and Transy, C. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25, 5570-5574.
17. Emond, C., Michalek, J. E., Birnbaum, L. S., and DeVito, M. J. (2005). Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments. Environ. Health Perspect. 113, 1666-1668.
18. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268, 722-726.
19. Friedman, S. L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250.
20. Gouedard, C., Barouki, R., and Morel, Y. (2004a). Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 24, 5209-5222.
21. Gouedard, C., Barouki, R., and Morel, Y. (2004b). Induction of the paraoxonase- 1 gene expression by resveratrol. Arterioscler. Thromb. Vasc. Biol. 24, 2378-2383.
22. Hanada, K., Nakai, K., Tanaka, H., Suzuki, F., Kumada, H., Ohno, Y., Ozawa, S., and Ogata, H. (2012). Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development. Drug Metab. Pharmacokinet. 27, 301-306.
23. He, J., Hu, B., Shi, X., Weidert, E. R., Lu, P., Xu, M., Huang, M., Kelley, E. E., and Xie, W. (2013). Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol. Cell. Biol. 33, 2047-2055. doi: 10.1128/ MCB.01658-12.
24. Helfman, D.M., Kim, E.J., Lukanidin, E., and Grigorian, M. (2005). The metastasis associated protein S100A4: Role in tumour progression and metastasis. Br. J. Cancer 92, 1955-1958. doi: 10.1038/sj.bjc.6602613.
25. Ikegami, T., Zhang, Y., and Matsuzaki, Y. (2007). Liver fibrosis: Possible involvement of EMT. Cells Tissues Organs 185, 213-221. doi: 10.1159/000101322.
26. Ikuta, T., and Kawajiri, K. (2006). Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp. Cell Res. 312, 3585- 3594. doi: 10.1016/j.yexcr.2006.08.002. pii: S0014-4827(06)00312-0.
27. Knittel, T., Kobold, D., Saile, B., Grundmann, A., Neubauer, K., Piscaglia, F., and Ramadori, G. (1999). Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117, 1205-1221.
28. Kokkinos, M. I., Wafai, R., Wong, M. K., Newgreen, D. F., Thompson, E. W., and Waltham, M. (2007). Vimentin and epithelial-mesenchymal transition in human breast cancer-Observations in vitro and in vivo. Cells Tissues Organs 185, 191-203. doi: 10.1159/000101320.
29. Lee, J. H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M. J., Gonzalez, F. J., and Xie, W. (2010). A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology 139, 653-663. doi: 10.1053/j.gastro.2010.03.033.
30. Lehmann, G. M., Xi, X., Kulkarni, A. A., Olsen, K. C., Pollock, S. J., Baglole, C. J., Gupta, S., Casey, A. E., Huxlin, K. R., Sime, P. J., et al. (2011). The aryl hydrocarbon receptor ligand ITE inhibits TGFß1-induced human myofibroblast differentiation. Am. J. Pathol. 178, 1556-1567. doi: 10.1016/j. ajpath.2010.12.025.
31. Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., and Mallat, A. (2005). Hepatic fibrosis: Molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 45, 605-628. doi:10.1146/annurev. pharmtox.45.120403.095906
32. Mallat, A., and Lotersztajn, S. (2009). Cigarette smoke exposure: A novel cofactor of NAFLD progression? J. Hepatol. 51, 430-432. doi: 10.1016/j. jhep.2009.05.021.
33. Mandal, P. K. (2005). Dioxin: A review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. B 175, 221-230. doi: 10.1007/s00360-005-0483-3.
34. Marinkovic, N., Pašalic, D., Ferencak, G., Grškovic, B., and Stavljenic Rukavina, A. (2010). Dioxins and human toxicity. Arh. Hig. Rada Toksikol. 61, 445-453. doi: 10.2478/10004-1254-61-2010-2024.
35. Nault, R., Kim, S., and Zacharewski, T. R. (2013). Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice. Toxicol. Appl. Pharmacol. 267, 184-191. doi: 10.1016/j.taap.2012.11.028.
36. Okey, A. B. (2007). An aryl hydrocarbon receptor odyssey to the shores of toxicology: The Deichmann Lecture, International Congress of Toxicology-XI. Toxicol. Sci. 98, 5-38. doi: 10.1093/toxsci/kfm096.
37. Pessione, F., Ramond, M. J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., Rueff, B., Valla, D. C., and Degos, F. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34, 121-125. doi: 10.1053/jhep.2001.25385.
38. Rico-Leo, E. M., Alvarez-Barrientos, A., and Fernandez-Salguero, P. M. (2013). Dioxin receptor expression inhibits basal and transforming growth factor ß-induced epithelial-to-mesenchymal transition. J. Biol. Chem. 288, 7841-7856. doi: 10.1074/jbc.M112.425009.
39. Rowe, R. G., Lin, Y., Shimizu-Hirota, R., Hanada, S., Neilson, E. G., Greenson, J. K., and Weiss, S. J. (2011). Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol. Cell. Biol. 31, 2392-2403. doi: 10.1128/ MCB.01218-10.
40. Sugimoto, H., Mundel, T. M., Kieran, M. W., and Kalluri, R. (2006). Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 5, 1640-1646.
41. Taura, K., Miura, K., Iwaisako, K., Osterreicher, C. H., Kodama, Y., Penz-Osterreicher, M., and Brenner, D. A. (2010). Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036. doi: 10.1002/hep.23368
42. Tomkiewicz, C., Herry, L., Bui, L. C., Metayer, C., Bourdeloux, M., Barouki, R., and Coumoul, X. (2012). The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway. Oncogene. 2013 April 4; 32, 1811-1820. doi:10.1038/onc.2012.197
43. Zaher, H., Fernandez-Salguero, P. M., Letterio, J., Sheikh, M. S., Fornace, A. J., Jr, Roberts, A. B., and Gonzalez, F. J. (1998). The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol. Pharmacol. 54, 313-321.
44. Zein, C. O. (2010). Clearing the smoke in chronic liver diseases. Hepatology 51, 1487-1490. doi: 10.1002/hep.23694.
45. Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., and Kalluri, R. (2007). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337-23347. doi: 10.1074/jbc.M700194200.